Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers July 20, 2018
Pharmacy Choice - Pharmacy News - July 20, 2018

Pharmacy News

Today's Pharmaceutical and Pharmacy News
Daily News Topic:

FDA News
7/19/18 - FDA Approves First Cancer Drug Through New Oncology Review Pilot That Enables Greater Development Efficiency
This is the first approval that FDA has granted as a part of two new pilot programs announced earlier this year that collectively aim to make the development and review of cancer drugs more efficient, while improving FDA' s rigorous standard for evaluating efficacy and safety. With this real-time review, the FDA was able to start evaluating the cli
7/19/18 - FDA approves Janssens Symtuza single-tablet regimen for HIV-1 [All Iraq News Agency (AIN)]
The US Food and Drug Administration has granted approval to Janssen Pharmaceutical Companies single-tablet regimen Symtuza to treat human immunodeficiency virus type 1. Cobicistat, emtricitabine and tenofovir alafenamide are provided by Gilead Sciences under a licensing agreement with Janssen. Janssen Pharmaceutica Infectious Diseases, Late...
7/19/18 - FDA Approves New Indications for ZOMACTON® (somatropin) as Ferring Plans Launch of Needle-Free Delivery System
Ferring Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved ZOMACTON for injection in four additional pediatric indications:. It is estimated that around 3-5% of children in the United States have short stature, defined as a height below the 3rd percentile. â??Parents struggle to deliver their childâ?? s dai
7/19/18 - FDA Oks Novartis' Kisqali For Use In Pre/Perimenopausal Women With Breast Cancer
BASEL- The U.S. Food and Drug Administration approved Kisqali or ribociclib in combination with an aromatase inhibitor for the treatment of pre/perimenopausal or postmenopausal women with hormone receptor- positive, human epidermal growth factor receptor 2- negative advanced or metastatic breast cancer, as initial endocrine-based therapy.
7/19/18 - LabCorp Launches Proprietary UltraQual® Multiplex PCR Assay for HCV, HIV-1, HIV-2 and HBV
By a News Reporter-Staff News Editor at Gene Therapy Weekly-- LabCorp ®, a leading global life sciences company, announced that it has received approval from the U.S. Food and Drug Administration for the UltraQual ® Multiplex PCR Assay for HCV, HIV-1, HIV-2 and HBV for screening of donated blood plasma. This innovative assay, which was developed
7/19/18 - Sun Pharma gets USFDA nod for cancer treatment injection [Algeria Press Service]
Drug major Sun Pharmaceutical Industries today said it has received approval from the US health regulator for its INFUGEM injection used for treatment of cancer. This is the first US Food and Drug Administration approval for a product from the company`s Halol facility after receipt of Establishment Inspection Report in June 2018, Sun Pharma said in

Chain Drug Review
Chain Drug Review Magazine Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.
Featured Article from Chain Drug Review:
AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
Pharmacy Spanish
This lesson is supported by:

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Websites »
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement